Aprea TherapeuticsAPRE
13F holders, Q2 2026 (June 30)At the end of Q2 2026, 27 institutions reported holding Aprea Therapeutics Inc. (APRE) in their 13F filings, up 5 from Q1 2026. 7 opened new positions and 2 sold out. The largest holders were AIGH Capital Management LLC ($815K), Vestal Point Capital, LP ($281K) and Sphera Funds Management LTD. ($217K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Aprea Therapeutics Inc.
- CUSIP
- 03836J201
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $112K |
| Exits | 2 | $56K |
All 13F filers, Q1 2026 → Q2 2026: 254,560 shares bought and 128,061 shares sold, net +126,499 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 27 holders
| AIGH Capital Management LLC | 0.07% | No change | 1,015,541 | $815K |
| Vestal Point Capital, LP | 0.01% | No change | 350,000 | $281K |
| Sphera Funds Management LTD. | 0.03% | No change | 270,000 | $217K |
| Nantahala Capital Management, LLC | 0.01% | No change | 205,760 | $165K |
| Renaissance Technologies | 0.00% | Add +321.5% | 105,800 | $85K |
| Geode Capital Management, LLC | 0.00% | Reduce -37.1% | 74,869 | $60K |
| Citadel Advisors | 0.00% | New | 58,600 | $47K |
| BNP Paribas Financial Markets | 0.00% | Add +13.6% | 45,211 | $36K |
| Diadema Partners LP | 0.01% | New | 44,907 | $36K |
| Vanguard Fiduciary Trust Co. | 0.00% | No change | 38,464 | $31K |
| Susquehanna International Group, LLP | 0.00% | Add +168.4% | 34,939 | $28K |
| Morgan Stanley | 0.00% | Add +15.7% | 25,830 | $21K |
| Vanguard Capital Management LLC | 0.00% | Add +16.6% | 22,882 | $18K |
| LPL Financial LLC | 0.00% | Reduce -23.8% | 16,052 | $13K |
| HighTower Advisors, LLC | 0.00% | No change | 13,864 | $11K |
| Northern Trust Corp. | 0.00% | New | 13,705 | $11K |
| Persistent Asset Partners Ltd | 0.00% | New | 11,490 | $9K |
| XTX Topco Ltd | 0.00% | New | 10,565 | $8K |
| BlackRock, Inc. | 0.00% | Reduce -15.7% | 7,173 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -30.0% | 3,590 | $3K |
| Group One Trading LLC | 0.00% | No change | 577 | $463 |
| Barclays PLC | 0.00% | New | 473 | $379 |
| Osaic Holdings, Inc. | 0.00% | No change | 295 | $236 |
| WealthCollab, LLC | 0.00% | No change | 158 | $127 |
| FMR LLC | 0.00% | New | 45 | $36 |
| SBI Securities Co., Ltd. | 0.00% | No change | 16 | $13 |
| UBS Group AG | 0.00% | Reduce -99.9% | 3 | $2 |
"% of holder's portfolio" is APRE's weight in each manager's 13F, not the share of Aprea Therapeutics Inc. the manager owns.